Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t image

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Apr 08, 2026
12:00PM - 01:00PM EDT
Online Event
Overview

Join leading experts Dr. Michael Misialek & Dr. Andrew Yee for an in-depth, patient-friendly webinar designed to help individuals with multiple myeloma better understand their lab results. In this educational session, doctors Misialek and Yee will explain in plain language what common blood and bone marrow tests measure, why they are ordered, and how results guide treatment and monitoring decisions. Participants will learn about monitoring lab trends over time helping to reduce anxiety and build confidence. The webinar will help patients feel more confident and prepared for their next appointment by increasing their familiarity with common lab tests, what the results mean, and how those results are used in care decisions, empowering them to engage more comfortably in conversations with their healthcare team. In addition, attendees will gain insight into advances in myeloma testing, emerging biomarkers, and how newer diagnostic tools are driving more personalized treatment and disease monitoring. This program is ideal for patients and caregivers seeking clarity, confidence, and a deeper understanding of multiple myeloma lab testing and personalized care.

 

Agenda
12:00 PM
Introductions
Cynthia Cahoon, RN

Cindy introduces the agenda of the event and featured speakers Dr. Michael Misialek & Dr. Andrew Yee

12:05 PM
Presentation
Dr. Michael Misialek & Dr. Andrew Yee

Dr. Michael Misialek & Dr. Andrew Yee discuss myeloma labs, what they mean and what they don't. 

12:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Cynthia Cahoon, RN

Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Healthtree contact Andrew J. Yee, MD

Andrew J. Yee, MD

Andrew J. Yee, MD is the Clinical Director of the Center for Multiple Myeloma at Massachusetts General Hospital, Mass General Brigham Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School. He received his medical degree from Harvard Medical School, followed by training in internal medicine at Massachusetts General Hospital and hematology and oncology at Dana-Farber Cancer Institute/Partners Cancer Care. He sees patients with multiple myeloma and plasma cell dyscrasias. He is actively involved in clinical trials in multiple myeloma, where he leads several investigator-initiated trials and serves as principal investigator on a range of multicenter trials.
Healthtree contact Michael J. Misialek, MD

Michael J. Misialek, MD

Dr. Misialek currently serves as Chair of Pathology at Newton-Wellesley Hospital, Newton, MA, part of the Mass General Brigham system. He is the Medical Director of chemistry, point-of-care testing, central processing and phlebotomy. He is a clinical assistant professor of pathology at Tufts University School of Medicine where he regularly instructs medical students and pathology residents. He is a Visiting Scientist at the Massachusetts Institute of Technology. He is the immediate past president of the Massachusetts Society of Pathologists. Dr. Misialek is a strong advocate for pathology and is very active in the College of American Pathologists, having served on numerous committees. His passion is to make widely known the value that pathologists bring to the health care team.